Soria JC - Search Results

1

Hartl DM, Bahleda R, Hollebecque A, Bosq J, Massard C, Soria JC. Hartl DM, et al. Among authors: soria jc. Ann Oncol. 2012 Jan;23(1):276-278. doi: 10.1093/annonc/mdr515. Epub 2011 Nov 4. Ann Oncol. 2012. PMID: 22056850 Free article. No abstract available.

2

Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy.

Soria JC, Fizazi K, Piron D, Kramar A, Gerbaulet A, Haie-Meder C, Perrin JL, Court B, Wibault P, Théodore C. Soria JC, et al. Ann Oncol. 1997 Nov;8(11):1089-98. doi: 10.1023/a:1008248319036. Ann Oncol. 1997. PMID: 9426328 Free article.

3

Do all patients with advanced non-small-cell lung cancer benefit from cisplatin-based combination therapy?

Soria JC, Brisgand D, Le Chevalier T. Soria JC, et al. Ann Oncol. 2001 Dec;12(12):1667-70. doi: 10.1023/a:1013574413217. Ann Oncol. 2001. PMID: 11843242 Free article. Clinical Trial.

4

Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer.

Andre F, Cabioglu N, Assi H, Sabourin JC, Delaloge S, Sahin A, Broglio K, Spano JP, Combadiere C, Bucana C, Soria JC, Cristofanilli M. Andre F, et al. Among authors: soria jc. Ann Oncol. 2006 Jun;17(6):945-51. doi: 10.1093/annonc/mdl053. Epub 2006 Apr 20. Ann Oncol. 2006. PMID: 16627550 Free article.

5

High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity.

Fizazi K, Morat L, Chauveinc L, Prapotnich D, De Crevoisier R, Escudier B, Cathelineau X, Rozet F, Vallancien G, Sabatier L, Soria JC. Fizazi K, et al. Among authors: soria jc. Ann Oncol. 2007 Mar;18(3):518-21. doi: 10.1093/annonc/mdl419. Ann Oncol. 2007. PMID: 17322541 Free article.

6

Targeted therapies in lung cancer.

Besse B, Ropert S, Soria JC. Besse B, et al. Among authors: soria jc. Ann Oncol. 2007 Jul;18 Suppl 9:ix135-42. doi: 10.1093/annonc/mdm308. Ann Oncol. 2007. PMID: 17631566 Free article. Review. No abstract available.

7

Drug insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy.

Loriot Y, Perlemuter G, Malka D, Penault-Llorca F, Boige V, Deutsch E, Massard C, Armand JP, Soria JC. Loriot Y, et al. Among authors: soria jc. Nat Clin Pract Oncol. 2008 May;5(5):268-78. doi: 10.1038/ncponc1087. Epub 2008 Mar 18. Nat Clin Pract Oncol. 2008. PMID: 18349858 Review.

8

Rhinitis and epistaxis in patients treated by anti-angiogenic therapy.

Prulière-Escabasse V, Escudier E, Balheda R, Soria JC, Coste A, Massard C. Prulière-Escabasse V, et al. Among authors: soria jc. Invest New Drugs. 2009 Jun;27(3):285-6. doi: 10.1007/s10637-008-9168-6. Epub 2008 Aug 27. Invest New Drugs. 2009. PMID: 18754078

9

Wound healing delay after central venous access following DCF/VEGF-trap therapy.

Ferté C, Massard C, Moldovan C, Desruennes E, Loriot Y, Soria JC. Ferté C, et al. Among authors: soria jc. Invest New Drugs. 2009 Dec;27(6):583-5. doi: 10.1007/s10637-009-9227-7. Epub 2009 Feb 17. Invest New Drugs. 2009. PMID: 19221694

10

From theoretical synergy to clinical supra-additive toxicity.

Soria JC, Massard C, Izzedine H. Soria JC, et al. J Clin Oncol. 2009 Mar 20;27(9):1359-61. doi: 10.1200/JCO.2008.20.8595. Epub 2009 Feb 17. J Clin Oncol. 2009. PMID: 19224836 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

736 results

Search Page

Filters